CSIMarket
 
Biolase Inc   (BIOL)
 

Biolase Inc's Customers Performance

BIOL



 
BIOL's Source of Revenues During the corresponding time, Biolase Inc saw a revenue deteriorated by -3.39 % year on year, sequentially revenue fell by -2.14 %. While revenue at the Biolase Inc 's corporate clients

List of BIOL Customers




for the same period Biolase Inc revnue deteriorated by -3.39 % year on year, sequentially revenue fell by -2.14 %.

List of BIOL Customers

Biolase Inc's Business Units
United States    79.43 % of total Revenue
International    25.08 % of total Revenue
Revenue Recognized Over Time    12.11 % of total Revenue
Revenue Recognized at a Point in Time    92.4 % of total Revenue
End-customer    79.43 % of total Revenue
Distributors    25.08 % of total Revenue






Biolase Inc's Comment on Sales, Marketing and Customers



The company provides training and clinical education on its products to dental practitioners, offering introductory, advanced, and specialized courses. It distributes products primarily directly to dental practitioners in the U.S. through field and in-house sales teams, while utilizing independent distributors in Canada, Europe, the Middle East, Latin America, and the Asia-Pacific region. The company seeks to expand sales to group practices, group purchasing organizations, and government channels. Maintenance and support services are offered in the U.S. and internationally through certified technicians. The company plans to broaden its product portfolio for dental practitioners and explore adjacent medical fields, including ophthalmology, otolaryngology, orthopedics, podiatry, pain management, aesthetics/dermatology, veterinary, and consumer products. Additionally, it aims to increase revenue from consumables.





Biolase Inc’s Comment on Sales, Marketing and Customers


The company provides training and clinical education on its products to dental practitioners, offering introductory, advanced, and specialized courses. It distributes products primarily directly to dental practitioners in the U.S. through field and in-house sales teams, while utilizing independent distributors in Canada, Europe, the Middle East, Latin America, and the Asia-Pacific region. The company seeks to expand sales to group practices, group purchasing organizations, and government channels. Maintenance and support services are offered in the U.S. and internationally through certified technicians. The company plans to broaden its product portfolio for dental practitioners and explore adjacent medical fields, including ophthalmology, otolaryngology, orthopedics, podiatry, pain management, aesthetics/dermatology, veterinary, and consumer products. Additionally, it aims to increase revenue from consumables.








BIOL's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Biolase Inc 0.63 43.72 -32.95 250
SUBTOTAL 0.00 0.00 0.00 -

Sources: Biolase Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Biolase Inc’s corporate clients.
For your research, we’ve provided 9 tables on Biolase Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.